Socionext (6526) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
31 Jul, 2025Executive summary
Net sales for 1Q FY26/3 declined 34.5% year-over-year to ¥34.6 billion, mainly due to lower demand in China and yen appreciation.
Operating income dropped 86.0% year-over-year to ¥1.4 billion, with net income falling 93.9% to ¥0.5 billion.
Product revenue fell 38.8% and NRE revenue decreased 18.0% compared to the same quarter last year.
The company continues to focus on expanding design wins and high-growth areas such as automotive, data center & networking, and smart devices, with ongoing investments in advanced technologies.
Management expects sales to recover in the second half of FY26/3, driven by new mass production in automotive and other sectors.
Financial highlights
Gross margin improved to 58.3% in 1Q FY26/3 from 55.1% in FY25/3, while product gross margin rose to 44.4%.
Cash and cash equivalents at quarter-end were ¥69.5 billion as of June 30, 2025.
Shareholders’ equity ratio remained strong at 80.9%.
Net cash provided by operating activities increased to ¥10.0 billion from ¥4.6 billion year-over-year.
Operating margin fell sharply to 4.2% from 19.4% a year earlier.
Outlook and guidance
FY26/3 full-year net sales forecast at ¥175.0 billion, down 7.2% year-over-year; operating income forecast at ¥14.0 billion, down 44.0%.
Operating margin expected to be 8.0% for FY26/3, with improvement anticipated in the second half as new projects ramp up.
No revision to the previously announced earnings forecast.
Aggressive investment in R&D and leading-edge technologies will continue, impacting short-term profitability.
Assumed exchange rate for the fiscal year is 130 yen to the U.S. dollar.
Latest events from Socionext
- Sales rebounded, but profits and margins remain pressured by costs and FX; guidance unchanged.6526
Q3 202630 Jan 2026 - Sales guidance raised but profit outlook cut as margins shrink amid higher costs and weak demand.6526
Q2 202631 Oct 2025 - Sales and profit fell, but R&D and NRE revenue rose; treasury stock buyback approved.6526
Q2 202513 Jun 2025 - Net sales fell 14.1% but operating income and R&D investment both increased.6526
Q1 202513 Jun 2025 - Revenue and profit fell sharply, but investments and design wins support future growth.6526
Q4 20256 Jun 2025 - Net sales dropped 14.4% and the full-year outlook was cut amid weak China demand.6526
Q3 20255 Jun 2025